Skip to main content

Stratagene Launches New Multiplex PCR System

NEW YORK, Feb 22 – Stratagene has introduced a Mx4000 PCR instrument system designed specifically for multiplexed QPCR, the company said Thursday.

The system, which supports all available fluorescent dyes and performs real-time PCR, is the first of its kind, the company said. It is designed to perform PCR for allelic discrimination, mutational analysis, and quantification of single or multiplexed targets. The system also has software that allows users to view real-time amplification plots while a PCR experiment is in progress.

After the experiment is complete, the software allows users to formulate data amplification plots, scatter plots, threshold cycle values, and fluorescence intensity screens. Users can also analyze melting curves and multiple standard curves on the same plot, and evaluate selected sample wells independently.

"Quantitative PCR has rapidly become one of the most important technologies for genotyping and gene expression analysis,” Alex Szabo, Stratagene's vice president of marketing, said in a statement. “The ability to perform these assays under true multiplexed conditions greatly increases their reliability while reducing costs to researchers. Stratagene is proud to introduce an instrument that establishes a new benchmark of performance in this field."

The company did not disclose pricing information for the system.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.